Myth: every firm needs to focus (video)
@kuleuvenuniversity.bsky.social celebrates its 600 years anniversary. I enjoyed my visit of the nanocentre and Thomas Hertog's 600-second Einstein telecope lecture. Here's my own talk, even more concise (60 seconds!). Thanks to Skapa Media for putting camera-shy academics at ease! :) t.ly/IUFAO
Policy coordination is essential, but how can we measure and improve it effectively? Our latest paper (w/ A. Santos), published in Science and Public Policy, introduces a method that integrates expert assessment with automated content analysis. #PolicyCoordination #SemanticAnalysis tiny.cc/azeyzz
Thanks to POM for inviting me to deliver the #keynote for the #CrossS3 #Interreg France-Wallonie-Vlaanderen launch event. Great projects and high-quality teams!
Call for #post-docs who lived in a barren wasteland (=outside Belgium 😊) the past 2 yrs and interested in 1) submitting a “high-risk, high-reward” innovation research project + 2) carrying it out @KULeuven. #Funding for 3 yrs (+optional 2). DL 17 Feb ’25. Send dm if interested. tinyurl.com/5kk9vuwt
📢 #Conference announcement. Great venue to present & discuss the #economics of #science (broadly defined)! Submit your work for the 18th Workshop on the Organisation, Economics and Policy of Scientific Research (#WOEPS), 3-4 April 2025, #Strasbourg. Submit by 6 Jan 2025. More info: tiny.cc/sg3vzz
KU Leuven campus Opera in Antwerp
KU Leuven, in collaboration with Google, EPO, USPTO, UCD Dublin, and EPFL, invites you to the 9th Annual Summer School on Data and Algorithms for Science, Technology & Innovation (ST&I) Studies, 13-14 Sep, campus Opera in Antwerp. Submission DL: 15 June. More info: feb.kuleuven.be/drc/MSI/sti
Strategic Organization article cover page
Using text-based indicators in strategic management research is like, ehm..., bungee jumping! Better check whether the elastic cord is reliable. :) New paper in Strategic Organization. #exploration #exploitation #ambidexterity #contentanalysis #firmperformance shorturl.at/hKQY1
Nieuw Leuven Economisch Standpunt: 1) #farmabedrijven nemen gepatenteerde kandidaat-geneesmiddelen met sterkere wortels in wetenschappelijk #onderzoek gemakkelijker op in klinische studies, 2) nog meer als ze zélf het onderzoek deden, dus *R* en *D* “onder één dak”. shorturl.at/tFHP3